Vanda Pharmaceuticals Inc. financial data

Symbol
VNDA on Nasdaq
Industry
Pharmaceutical Preparations
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, DC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 479 % -19.3%
Quick Ratio 1.63 % +33.4%
Debt-to-equity 19.6 % +0.88%
Return On Equity -3.02 % -237%
Return On Assets -2.52 % -237%
Operating Margin -19.6 % -18067%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.3M shares +1.35%
Common Stock, Shares, Outstanding 58.3M shares +1.35%
Entity Public Float 369M USD -38.7%
Common Stock, Value, Issued 58K USD 0%
Weighted Average Number of Shares Outstanding, Basic 58.3M shares +1.29%
Weighted Average Number of Shares Outstanding, Diluted 58.3M shares +1.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 191M USD -9.91%
Revenue from Contract with Customer, Excluding Assessed Tax 191M USD -9.91%
Research and Development Expense 78.9M USD +11.3%
Costs and Expenses 228M USD +7.66%
Operating Income (Loss) -37.5M USD -16265%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.1M USD -203%
Income Tax Expense (Benefit) -1.7M USD -129%
Net Income (Loss) Attributable to Parent -16.4M USD -239%
Earnings Per Share, Basic -0.29 USD/shares -245%
Earnings Per Share, Diluted -0.29 USD/shares -245%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 100M USD -45.1%
Accounts Receivable, after Allowance for Credit Loss, Current 42.8M USD +46.1%
Inventory, Net 1.61M USD +60.4%
Assets, Current 432M USD -19.4%
Deferred Income Tax Assets, Net 79.4M USD +17.1%
Property, Plant and Equipment, Net 2.18M USD +2.35%
Operating Lease, Right-of-Use Asset 6.02M USD -19%
Assets 645M USD +0.55%
Employee-related Liabilities, Current 6.69M USD +31.6%
Liabilities, Current 89.1M USD +5.01%
Operating Lease, Liability, Noncurrent 5.49M USD -26.6%
Other Liabilities, Noncurrent 9.32M USD +50.4%
Liabilities 104M USD +5.47%
Accumulated Other Comprehensive Income (Loss), Net of Tax 702K USD
Retained Earnings (Accumulated Deficit) -169M USD -10.7%
Stockholders' Equity Attributable to Parent 541M USD -0.35%
Liabilities and Equity 645M USD +0.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.57M USD -76.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -18.2M USD -110%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 58.3M shares +1.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 101M USD -45%
Deferred Tax Assets, Valuation Allowance 8.55M USD +19.8%
Deferred Tax Assets, Gross 85.9M USD +1.2%
Operating Lease, Liability 9.4M USD -15.6%
Depreciation 206K USD -29.2%
Payments to Acquire Property, Plant, and Equipment 7K USD -86.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.7M USD -220%
Lessee, Operating Lease, Liability, to be Paid 11.2M USD -19%
Property, Plant and Equipment, Gross 13.2M USD +1.74%
Operating Lease, Liability, Current 2.45M USD +3.37%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.8M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.73M USD +2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -246K USD -112%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.79M USD -33.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.41M USD -13.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 18.3M USD +18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.16M USD -10.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.47M USD +327%
Deferred Tax Assets, Net of Valuation Allowance 75M USD +1.3%
Share-based Payment Arrangement, Expense 12.8M USD -11.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%